Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.

Tarkiainen, M; Tynjälä, P; Vähäsalo, P; Lahdenne, P

Tarkiainen, M; Tynjälä, P; Vähäsalo, P; Lahdenne, P.

Scand J Rheumatol ; 40(2): 150-2, 2011 Mar.

Article in En | MEDLINE | ID: mdl-20868307

Subject(s)

Antibodies, Monoclonal/therapeutic use; Arthritis, Juvenile/drug therapy; Immunoglobulin G/therapeutic use; Inflammatory Bowel Diseases/epidemiology; Receptors, Tumor Necrosis Factor/therapeutic use; Adolescent; Antibodies, Monoclonal/adverse effects; Antirheumatic Agents/adverse effects; Antirheumatic Agents/therapeutic use; Arthritis, Juvenile/complications; Arthritis, Juvenile/immunology; Child; Etanercept; Female; Finland; HLA-B27 Antigen/blood; Humans; Immunoglobulin G/adverse effects; Incidence; Inflammatory Bowel Diseases/chemically induced; Inflammatory Bowel Diseases/etiology; Infliximab; Male; Retrospective Studies; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile / Immunoglobulin G / Inflammatory Bowel Diseases / Receptors, Tumor Necrosis Factor / Antibodies, Monoclonal Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Scand J Rheumatol Year: 2011 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google